Hostname: page-component-78c5997874-8bhkd Total loading time: 0 Render date: 2024-11-07T16:35:33.573Z Has data issue: false hasContentIssue false
  • English
  • Français

Tryptophan Metabolism in Affective Psychoses

Published online by Cambridge University Press:  29 January 2018

C. L. Cazzullo ,
A. Mangoni  and
G. Mascherpa
C. L. Cazzullo
Affiliation:
University of Milan Medical School, Milan, Italy
A. Mangoni
Affiliation:
University of Milan Medical School, Milan, Italy
G. Mascherpa
Affiliation:
University of Milan Medical School, Milan, Italy
Get access Rights & Permissions [Opens in a new window]

Extract

Tryptophan has attracted attention during recent years for the possible role played by some of its metabolites in the aetiology and treatment of psychiatric disorders. Of these metabolites, serotonin has received special attention and considerable work has been carried out in order to elucidate its physiological and pharmacological actions. Studies from animal experiments are thus available on the function of serotonin in nervous activity (Marrazzi and Hart, 1955; Brodie et al., 1955; Pletscher et al., 1956; Welsh, 1957), but the results obtained thus far in psychiatric patients are uncertain. Recent researches in the affective psychoses (Burgermeister et al., 1963) did not reveal significant differences between patients and normal controls in the urinary output of 5-hydroxyindoleacetic acid (5-HIAA) before or after an oral 5-hydroxytryptophan load.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 112 , Issue 483 , February 1966 , pp. 157 - 162
Copyright
Copyright © Royal College of Psychiatrists, 1966 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Benassi, C. A., Benassi, P., Allegri, G., and Ballarin, P. (1961). “Tryptophan metabolism in schizophrenic patients.” J. Neurochem., 7, 264–70.Google Scholar
Brodie, B. B., Pletscher, A., and Shore, P. A. (1955). “Evidence that serotonin has a role in brain function.”. Science, 122, 968.CrossRefGoogle Scholar
Burgermeister, J. J., Dick, P., Garonne, G., Guggisberg, M., and Tissot, R. (1963). “Excretion urinaire de l'acide 5-hydroxyindolacétique chez 150 malades atteints de syndrome dépressif et d'agitation maniaque.” Presse méd., 71, 1116–18.Google Scholar
Coppen, A., Shaw, D. M., and Farrell, J. P. (1963). “Potentiation of the antidepressive effect of a monoamine-oxidase inhibitor by tryptophan.” Lancet, Jan. 12, 79–81.CrossRefGoogle Scholar
Knox, W. E., and Mehler, A. H. (1951). “The adaptive increase of the typtophan peroxidase-oxidase system of liver.” Science, 113, 237–8.Google Scholar
Knox, W. E., and Mehler, A. H., and Auerbach, V. H. (1955). “The hormonal control of tryptophan peroxidase in the rat.” J. biol. Chem., 214, 307–13.CrossRefGoogle ScholarPubMed
Mangoni, A., and Mascherpa, G. (1963). “Alcuni aspetti del metabolismo del triptofano nelle psicosi affettive.” Lav. neuropsichiat., 33, 160–2.Google Scholar
Mangoni, A., Paolucci, A. M., and Spadoni, M. A. (1956). “Modificazioni dell’ azoto totale e dell’ attivitá triptofanoperossidasica del fegato di animali digiu-nanti normali e surrenectomizzati.” Quad. Nutr., 16, 115–22.Google Scholar
Marrazzi, A. S., and Hart, E. R. (1955). “Relationship of hallucinogens to adrenergic cerebral neurohumors.” Science, 121, 365–7.Google Scholar
Michael, A. F., Drummond, K. N., Doeden, D., Anderson, J. A., and Good, R. A. (1964). “Tryptophan metabolism in man.” J. clin. Invest., 43, 1730–46.CrossRefGoogle ScholarPubMed
Munro, H. N., Steele, M. H., and Hutchison, W. C. (1963.) “Blood corticosterone-levels in the rat after administration of amino-acids.” Nature, 199, 1182–3.CrossRefGoogle ScholarPubMed
Pletscher, A., Shore, P. A., and Brodie, B. B. (1956). “Serotonin as a mediator of reserpine action in brain.” J. Pharmacol, exp. Therap., 116, 84–89.Google ScholarPubMed
Price, J. M. (1954). “The determination of N-methyl-2-pyridone-5-carboxamide in human urine.” J. biol. Chem., 211, 117–24.CrossRefGoogle ScholarPubMed
Rosen, F., Lowy, R. S., and Sprince, H. (1951). “A rapid assay for xanthurenic acid in urine.” Proc. Soc. exper. Biol. Med., 77, 399–401.Google Scholar
Thomson, J. F., and Mikuta, E. T. (1954a). “Effect of total body X-irradiation on the tryptophan peroxidase activity of rat liver.” Proc. Soc. exp. Biol. Med., 85, 29–32.Google Scholar
Thomson, J. F., and Mikuta, E. T. (1954b). “The effect of cortisone and hydrocortisone on the tryptophan peroxidase-oxidase activity of rat liver.” Endocrinology, 55, 232–3.Google Scholar
Udenfriend, S., Titus, E., and Weissbach, H. (1955). “The identification of 5-hydroxy-3-indoleacetic acid in normal urine and a method for its assay.” J. biol. Chem., 216, 499–505.CrossRefGoogle Scholar
Welsh, J. H. (1957). “Serotonin as a possible neurohumoral agent: evidence obtained in lower animals.” Ann. N.Y. Acad. Sci., 66, 618–30.CrossRefGoogle ScholarPubMed
Woolley, D. W. (1962). The Biochemical Bases of Psychoses. John Wiley and Sons Inc., Ed., New York, London.Google Scholar
Yemm, E. W., and Cocking, E. C. (1955). “The determination of amino-acids with ninhydrin.” Analyst, 80, 209–13.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.